SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001159036-21-000022
Filing Date
2021-05-03
Accepted
2021-05-03 16:03:32
Documents
14
Period of Report
2021-05-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K halo-20210501.htm   iXBRL 8-K 38029
  Complete submission text file 0001159036-21-000022.txt   179100

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT halo-20210501.xsd EX-101.SCH 2436
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT halo-20210501_cal.xml EX-101.CAL 722
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT halo-20210501_def.xml EX-101.DEF 1659
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT halo-20210501_lab.xml EX-101.LAB 24275
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT halo-20210501_pre.xml EX-101.PRE 12658
7 EXTRACTED XBRL INSTANCE DOCUMENT halo-20210501_htm.xml XML 10772
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32335 | Film No.: 21883483
SIC: 2836 Biological Products, (No Diagnostic Substances)